For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241115:nRSO3355Ma&default-theme=true
RNS Number : 3355M Coca-Cola Europacific Partners plc 15 November 2024
THIS ANNOUNCEMENT DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT
DOCUMENT AND NEITHER THIS ANNOUNCEMENT NOR ANYTHING HEREIN FORMS THE BASIS FOR
ANY OFFER TO PURCHASE OR SUBSCRIBE FOR ANY SHARES OR OTHER SECURITIES IN THE
COMPANY NOR SHALL IT FORM THE BASIS FOR ANY CONTRACT OR COMMITMENT WHATSOEVER.
15 November 2024
Coca-Cola Europacific Partners plc
Transfer to the Equity Shares (Commercial Companies) category
Further to the announcement on 18 October 2024, Coca-Cola Europacific Partners
plc ("CCEP" or the "Company") is pleased to announce the approval by the
Financial Conduct Authority (the "FCA") of the transfer of the listing
category of its ordinary shares from the Equity Shares (Transition) category
to the Equity Shares (Commercial Companies) category of the Official List of
the FCA (the "Transfer") which became effective at 8:00 a.m. (GMT) today.
Following the transfer and subject to other conditions being met, including a
sufficient volume of its trading in the ordinary shares migrating to UK equity
trading venues(1), the Company should, subject to FTSE approval, be eligible
in due course for admission to the FTSE UK Index Series.
The FTSE UK Index Series Guide to Calculation Method for the Median Liquidity
Test ("the Liquidity Test") requires that as a pre-requisite to future FTSE
indexation eligibility, a minimum of 0.025% of the Company's traded free float
to be traded on UK equity trading venues(1) against the sterling quote over
certain periods. This is calculated on a median monthly basis and is currently
equivalent to c.51k (or c. £3.1m) ordinary shares per day. Subject to the
outcome of the Liquidity Test being satisfactory, in each month from November
2024 up to and including February 2025, the earliest it could be satisfied is
ahead of FTSE Russell's quarterly rebalancing review in March 2025. There can
be no certainty that the Liquidity Test will be met.
About CCEP
CCEP is one of the world's leading consumer goods companies. We make, move and
sell some of the world's most loved brands - serving nearly 600 million
consumers and helping over 4 million customers across 31 countries grow. We
combine the strength and scale of a large, multi-national business with an
expert, local knowledge of the customers we serve and communities we support.
For more information about CCEP, please visit www.cocacolaep.com
(http://www.cocacolaep.com/) & follow CCEP on LinkedIn @CCEP
(https://www.linkedin.com/company/coca-cola-europacific-partners/) . For a
copy of CCEP's latest factsheet: Presentation Title (cocacolaep.com)
(https://ir.cocacolaep.com/static-files/572c7fa4-eff9-4317-becb-1433f83f3503)
Enquiries
Corporate broker, joint sponsor and joint financial adviser BNP Paribas:
Virginia Khoo virginia.khoo@uk.bnpparibas.com
(mailto:virginia.khoo@uk.bnpparibas.com)
Corporate broker, joint sponsor and joint financial adviser Deutsche Numis:
Lewis Burnett lewis.burnett@dbnumis.com (mailto:lewis.burnett@dbnumis.com)
General Counsel and Company Secretary: Clare Wardle secretariat@ccep.com
Investor Relations: Sarah Willett sarah.willett@ccep.com
(mailto:sarah.willett@ccep.com)
Media: ccep@portland-communications.com
(mailto:ccep@portland-communications.com)
(1) Section 2.1.6 of the FTSE UK Index Series Guide to Calculation Method for
the Median Liquidity Test, v2.9 October 2024, lists volumes trading on the
following venues which will be aggregated for the purpose of the liquidity
test; The London Stock Exchange, CBOE CXE, CBOE BXE and CBOE OTC.
Forward-Looking Statements
This announcement contains statements, estimates or projections that
constitute "forward-looking statements" concerning the financial condition,
performance, strategy and objectives of Coca-Cola Europacific Partners plc and
its subsidiaries (together CCEP or the Group). Generally, the words
"ambition", "target", "aim", "believe", "expect", "intend", "estimate",
"anticipate", "project", "plan", "seek", "may", "could", "would", "should",
"might", "will", "forecast", "outlook", "guidance", "possible", "potential",
"predict", "objective" and similar expressions identify forward-looking
statements, which generally are not historical in nature. Forward-looking
statements are subject to certain risks that could cause actual results to
differ materially from CCEP's historical experience and present expectations
or projections including that there can be no assurance whether or when our
ordinary shares will meet the Liquidity Test or be admitted to FTSE UK Index
Series. As a result, undue reliance should not be placed on forward-looking
statements, which speak only as of the date on which they are made.
Due to these risks, CCEP's actual future financial condition, results of
operations, and business activities, including its results, dividend payments,
capital and leverage ratios, growth, including growth in revenue, cost of
sales per unit case and operating profit, free cash flow, market share, tax
rate, efficiency savings, achievement of sustainability goals, including net
zero emissions and recycling initiatives, capital expenditures, and ability to
remain in compliance with existing and future regulatory compliance, may
differ materially from the plans, goals, expectations and guidance set out in
forward-looking statements. These risks may also adversely affect CCEP's share
price. Additional risks that may impact CCEP's future financial condition and
performance are identified in filings with the SEC which are available on the
SEC's website at www.sec.gov. CCEP does not undertake any obligation to
publicly update or revise any forward-looking statements, whether as a result
of new information, future events, or otherwise, except as required under
applicable rules, laws and regulations. Any or all of the forward-looking
statements contained in this filing and in any other of CCEP's public
statements may prove to be incorrect.
End.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUSRWRSUUAAAA